Operating Lease, Liability, Current of HERON THERAPEUTICS, INC. /DE/ from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Operating Lease, Liability, Current for the quarter ending 31 Dec 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 -$3,037,000 -100% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $780,000 -$2,469,000 -76% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,539,000 -$1,655,000 -52% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,290,000 -$847,000 -27% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $3,037,000 -$38,000 -1.2% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $3,249,000 +$250,000 +8.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $3,194,000 +$614,000 +24% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $3,137,000 +$375,000 +14% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $3,075,000 +$381,000 +14% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $2,999,000 +$379,000 +14% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,580,000 +$31,000 +1.2% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,762,000 +$278,000 +11% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,694,000 +$277,000 +11% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $2,620,000 -$631,000 -19% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $2,549,000 -$613,000 -19% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $2,484,000 -$597,000 -19% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $2,417,000 -$580,000 -19% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $3,251,000 +$339,000 +12% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $3,162,000 +$332,000 +12% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,081,000 +$326,000 +12% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $2,997,000 +$1,071,000 +56% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $2,912,000 +$1,191,000 +69% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,830,000 +$1,108,000 +64% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $2,755,000 +$723,000 +36% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,926,000 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $1,721,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,722,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $2,032,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.